Hikma shells out $45.75M to buy bankrupt Teligent's Canadian assets
Hikma, a London-based generics maker, paid $45.75 million to snap up the Canadian assets of Teligent, which filed for bankruptcy last October.
Stay updated with breaking news from Teligent Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hikma, a London-based generics maker, paid $45.75 million to snap up the Canadian assets of Teligent, which filed for bankruptcy last October.
Teligent Pharma has announced a new recall that impacts its Lidocaine HCl Topical Solution USP 4% anesthetic liquid sold in 50ml glass bottles. The reason, the
The FDA conducted two drug recalls and urged the people to stop taking them and contact their doctors immediately.
– Detailed overview of the Desonide Market – Changes in industry market dynamics – Detailed market segmentation by type, application, etc. – Historical, current and projected market size in terms of quantity and value – Recent industry trends and developments – Competition situation of Desonide Market – Key companies and product strategies – Potential niche segment/region showing promising growth. Finally, the Desonide Market Report is the authoritative source for market research that can dramatically accelerate your business. The report shows economic conditions such as major...